S 2036New Jersey

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.

In committee

Jan 13, 2026: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee

Follow this bill Ratifi